Drug Shortage Report for ESOMEPRAZOLE

Last updated on 2022-01-18 History
Report ID 108844
Drug Identification Number 02442507
Brand name ESOMEPRAZOLE
Common or Proper name ESOMEPRAZOLE
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-04-06
Estimated end date Unknown
Actual end date 2022-01-17
Shortage status Resolved
Updated date 2022-01-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-01-18 English Compare
v7 2022-01-17 French Compare
v6 2022-01-17 English Compare
v5 2020-06-09 French Compare
v4 2020-06-09 English Compare
v3 2020-04-07 English Compare
v2 2020-03-17 French Compare
v1 2020-03-17 English Compare

Showing 1 to 8 of 8